Can changes in renal function predict variations in β-lactam concentrations in septic patients?

International Journal of Antimicrobial Agents

Volumn 42, Issue 5, 2013, Pages 422-428

  Casu, Giuseppe Stefano ^a   Hites, Maya ^a   Jacobs, Frederique ^a   Cotton, Frederic ^a   Wolff, Fleur ^a   Beumier, Marjorie ^a   De Backer, Daniel ^a   Vincent, Jean Louis ^a   Taccone, Fabio Silvio ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

Lactams; Creatinine clearance; Critically ill; Pharmacokinetics; Sepsis

Indexed keywords

BETA LACTAM ANTIBIOTIC; CEFEPIME; CEFTAZIDIME; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM;

ADULT; AGED; BELGIUM; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE CLEARANCE; DRUG CLEARANCE; DRUG MONITORING; FEMALE; GRAM NEGATIVE SEPSIS; HEMODIALYSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INTENSIVE CARE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; PHARMACODYNAMICS; PREDICTION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RELIABILITY;

CREATININE CLEARANCE; CRITICALLY ILL; PHARMACOKINETICS; SEPSIS; Β-LACTAMS;

AGED; ANTI-BACTERIAL AGENTS; BETA-LACTAMS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CREATININE; FEMALE; HUMANS; KIDNEY; KIDNEY FUNCTION TESTS; MALE; METABOLIC CLEARANCE RATE; MIDDLE AGED; PSEUDOMONAS INFECTIONS; SEPSIS; SERUM;

EID: 84885432082     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2013.06.021     Document Type: Conference Paper

References (35)

1. J.L. Vincent, J. Rello, J. Marshall, E. Silva, A. Anzueto, and C.D. Martin International study of the prevalence and outcomes of infection in intensive care units JAMA 302 2009 2323 2329
2. R.P. Dellinger, M.M. Levy, A. Rhodes, D. Annane, H. Gerlach, and S.M. Opal Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012 Intensive Care Med 39 2013 165 228
3. J.A. Roberts, and J. Lipman Pharmacokinetic issues for antibiotics in the critically ill patient Crit Care Med 37 2009 840 851
4. J. Roberts, M. Ulldemolins, M.S. Roberts, B. McWhinney, J. Ungerer, and D.L. Paterson Therapeutic drug monitoring of β-lactams in critically ill patients: proof of concept Int J Antimicrob Agents 36 2010 332 339
5. F.S. Taccone, P.F. Laterre, T. Dugernier, H. Spapen, I. Delattre, and X. Wittebole Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock Crit Care 14 2010 R126
6. A.A. Udy, J.A. Roberts, R.J. Boots, D.L. Paterson, and J. Lipman Augmented renal clearance: implications for antibacterial dosing in the critically ill Clin Pharmacokinet 49 2010 1 16
7. F. Pea, P. Viale, A. Candoni, F. Pavan, L. Pagani, and D. Damiani Teicoplanin in patients with acute leukaemia and febrile neutropenia: a special population benefiting from higher dosages Clin Pharmacokinet 43 2004 405 415
8. J.M. Conil, B. Georges, A. Breden, C. Segonds, M. Lavit, and T. Seguin Increased amikacin dosage requirements in burn patients receiving a once-daily regimen Int J Antimicrob Agents 28 2006 226 230
9. S.D. Hanes, G.C. Wood, V. Herring, M.A. Croce, T.C. Fabian, and E. Pritchard Intermittent and continuous ceftazidime infusion for critically ill trauma patients Am J Surg 179 2000 436 440
10. R. Brown, R. Babcock, J. Talbert, J. Gruenberg, C. Czurak, and M. Campbell Renal function in critically ill postoperative patients: sequential assessment of creatinine osmolar and free water clearance Crit Care Med 8 1980 68 72
11. A.A. Udy, J.M. Varghese, M. Altukroni, S. Briscoe, B.C. McWhinney, and J.P. Ungerer Subtherapeutic initial β-lactam concentrations in select critically ill patients: association between augmented renal clearance and low trough drug concentrations Chest 142 2012 30 39
12. U. Tröger, A. Drust, J. Martens-Lobenhoffer, I. Tanev, R.C. Braun-Dullaeus, and S.M. Bode-Böger Decreased meropenem levels in intensive care unit patients with augmented renal clearance: benefit of therapeutic drug monitoring Int J Antimicrob Agents 40 2012 370 372
13. J.P. Baptista, E. Sousa, P.J. Martins, and J.M. Pimentel Augmented renal clearance in septic patients and implications for vancomycin optimisation Int J Antimicrob Agents 39 2012 420 423
14. E. Ocampos-Martinez, L. Penaccini, S. Scolletta, A. Abdelhadii, A. Devigili, and S. Cianferoni Determinants of early inadequate vancomycin concentrations during continuous infusion in septic patients Int J Antimicrob Agents 39 2012 332 337
15. M.M. Levy, M.P. Fink, J.C. Marshall, E. Abraham, D. Angus, and D. Cook International Sepsis Definitions Conference. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference Intensive Care Med 29 2003 530 538
16. W.A. Knaus, E.A. Draper, D.P. Wagner, and J.E. Zimmerman APACHE II: a severity of disease classification system Crit Care Med 13 1985 818 829
17. J.L. Vincent, R. Moreno, J. Takala, S. Willatts, A. De Mendonça, and H. Bruining The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine Intensive Care Med 22 1996 707 710
18. F. Wolff, G. Deprez, L. Seyler, F. Taccone, M. Hites, and B. Gulbis Rapid quantification of six β-lactams to optimize dosage regimens in severely septic patients Talanta 103 2013 153 160
19. L. Seyler, F. Cotton, F.S. Taccone, D. De Backer, P. Macours, and J.L. Vincent Recommended β-lactam regimens are inadequate in septic patients treated with continuous renal replacement therapy Crit Care 15 2011 R137
20. European Committee on Antimicrobial Susceptibility Testing Breakpoint tables for interpretation of MICs and zone diameters Version 2.0, valid from 2012-01-01 2012 http://www.eucast.org/fileadmin/src/media/PDFs/EUCAST-files/ Breakpoint-tables/Breakpoint-table-v-2.0-120221.pdf [10.12.12]
21. J. Gonçalves-Pereira, and P. Póvoa Antibiotics in critically ill patients: a systematic review of the pharmacokinetics of β-lactams Crit Care 15 2011 R206
22. T.M. Chapuis, E. Giannoni, P.A. Majcherczyk, R. Chioléro, M.D. Schaller, and M.M. Berger Prospective monitoring of cefepime in intensive care unit adult patients Crit Care 14 2010 R51
23. A.M. Lovering, C.J. Vickery, D.S. Watkin, D. Leaper, C.M. McMullin, and L.O. White The pharmacokinetics of meropenem in surgical patients with moderate or severe infections J Antimicrob Chemother 36 1995 165 172
24. E. Polard, V. Le Bouquin, P. Le Corre, C. Kérebel, H. Trout, and A. Feuillu Non steady state and steady state PKS Bayesian forecasting and vancomycin pharmacokinetics in ICU adult patients Ther Drug Monit 21 1999 395 403
25. C. Li, J.L. Kuti, C.H. Nightingale, D.L. Mansfield, A. Dana, and D.P. Nicolau Population pharmacokinetics and pharmacodynamics of piperacillin/ tazobactam in patients with complicated intra-abdominal infection J Antimicrob Chemother 56 2005 388 395
26. E. Giannoni, P. Moreillon, J. Cotting, A. Moessinger, J. Bille, and L. Décosterd Prospective determination of plasma imipenem concentrations in critically ill children Antimicrob Agents Chemother 50 2006 2563 2568
27. G. Lugo, and G. Castañeda-Hernández Relationship between hemodynamic and vital support measures and pharmacokinetic variability of amikacin in critically ill patients with sepsis Crit Care Med 25 1997 806 811
28. P.E. Marik Aminoglycoside volume of distribution and illness severity in critically ill septic patients Anaesth Intensive Care 21 1993 172 173
29. G. Lugo-Goytia, and G. Castañeda-Hernández Bayesian approach to control of amikacin serum concentrations in critically ill patients with sepsis Ann Pharmacother 34 2000 1389 1394
30. J.M. Conil, B. Georges, O. Mimoz, E. Dieye, S. Ruiz, and P. Cougot Influence of renal function on trough serum concentrations of piperacillin in intensive care unit patients Intensive Care Med 32 2006 2063 2066
31. A. Udy, R. Boots, S. Senthuran, J. Stuart, R. Deans, and M. Lassig-Smith Augmented creatinine clearance in traumatic brain injury Anesth Analg 111 2010 1505 1510
32. D. Di Giantomasso, C.N. May, and R. Bellomo Vital organ blood flow during hyperdynamic sepsis Chest 124 2003 1053 1059
33. D. Di Giantomasso, C.N. May, and R. Bellomo Norepinephrine and vital organ blood flow during experimental hyperdynamic sepsis Intensive Care Med 29 2003 1774 1781
34. S.M. Bagshaw, S. Uchino, R. Bellomo, H. Morimatsu, S. Morgera, and M. Schetz Septic acute kidney injury in critically ill patients: clinical characteristics and outcomes Clin J Am Soc Nephrol 2 2007 431 439
35. A.A. Udy, J.A. Roberts, and J. Lipman Implications of augmented renal clearance in critically ill patients Nat Rev Nephrol 7 2011 539 543